- Home
- ADIL vs JNVR Comparison
ADIL vs JNVR Comparison
Compare ADIL & JNVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADIL
- JNVR
- Stock Information
- Founded
- ADIL 2010
- JNVR 2018
- Country
- ADIL United States
- JNVR United States
- Employees
- ADIL N/A
- JNVR N/A
- Industry
- ADIL Biotechnology: Pharmaceutical Preparations
- JNVR Finance: Consumer Services
- Sector
- ADIL Health Care
- JNVR Finance
- Exchange
- ADIL Nasdaq
- JNVR Nasdaq
- Market Cap
- ADIL 6.5M
- JNVR 7.3M
- IPO Year
- ADIL 2018
- JNVR 2023
- Fundamental
- Price
- ADIL $1.12
- JNVR $0.65
- Analyst Decision
- ADIL Strong Buy
- JNVR
- Analyst Count
- ADIL 1
- JNVR 0
- Target Price
- ADIL $8.00
- JNVR N/A
- AVG Volume (30 Days)
- ADIL 203.6K
- JNVR 198.6K
- Earning Date
- ADIL 11-13-2024
- JNVR 11-06-2024
- Dividend Yield
- ADIL N/A
- JNVR N/A
- EPS Growth
- ADIL N/A
- JNVR N/A
- EPS
- ADIL N/A
- JNVR N/A
- Revenue
- ADIL N/A
- JNVR $1,820,969.00
- Revenue This Year
- ADIL N/A
- JNVR N/A
- Revenue Next Year
- ADIL N/A
- JNVR N/A
- P/E Ratio
- ADIL N/A
- JNVR N/A
- Revenue Growth
- ADIL N/A
- JNVR N/A
- 52 Week Low
- ADIL $0.77
- JNVR $0.42
- 52 Week High
- ADIL $4.17
- JNVR $1.48
- Technical
- Relative Strength Index (RSI)
- ADIL 55.23
- JNVR 53.98
- Support Level
- ADIL $1.05
- JNVR $0.60
- Resistance Level
- ADIL $1.27
- JNVR $0.90
- Average True Range (ATR)
- ADIL 0.09
- JNVR 0.10
- MACD
- ADIL -0.00
- JNVR 0.01
- Stochastic Oscillator
- ADIL 46.88
- JNVR 43.30
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
About JNVR Janover Inc.
Janover Inc is a B2B fintech marketplace providing a platform for commercial property borrowers and lenders. It provides a technology platform that connects commercial mortgage borrowers looking for debt to refinance, build, or buy commercial property including apartment buildings to commercial property lenders including banks, credit unions, REITs, debt funds, and more looking to deploy capital into commercial mortgages. The firm caters to two consumer segments: lenders and borrowers. It derives the majority of its revenue from transaction fees.